Ed Ridley-Day
Stock Analyst at Rothschild & Co
(n/a)
# 5,013
Out of 5,182 analysts
9
Total ratings
n/a
Success rate
-27.8%
Average return
Main Sectors:
Stocks Rated by Ed Ridley-Day
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Neutral | $42 | $44.38 | -5.36% | 1 | Jan 12, 2026 | |
| DHR Danaher | Downgrades: Neutral | $245 → $220 | $178.33 | +23.37% | 1 | Oct 8, 2025 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $130 | $83.55 | +55.60% | 1 | Sep 18, 2025 | |
| SYK Stryker | Initiates: Neutral | $420 | $322.96 | +30.05% | 1 | Sep 18, 2025 | |
| QGEN Qiagen | Downgrades: Neutral | n/a | $34.29 | - | 1 | Apr 4, 2025 | |
| LNTH Lantheus Holdings | Initiates: Buy | $175 | $83.33 | +110.01% | 1 | Sep 3, 2024 | |
| ISRG Intuitive Surgical | Upgrades: Buy | $380 → $510 | $466.30 | +9.37% | 2 | Aug 2, 2024 | |
| GEHC GE HealthCare Technologies | Initiates: Buy | n/a | $69.58 | - | 1 | Jan 19, 2023 |
Medline
Jan 12, 2026
Initiates: Neutral
Price Target: $42
Current: $44.38
Upside: -5.36%
Danaher
Oct 8, 2025
Downgrades: Neutral
Price Target: $245 → $220
Current: $178.33
Upside: +23.37%
Zimmer Biomet Holdings
Sep 18, 2025
Initiates: Buy
Price Target: $130
Current: $83.55
Upside: +55.60%
Stryker
Sep 18, 2025
Initiates: Neutral
Price Target: $420
Current: $322.96
Upside: +30.05%
Qiagen
Apr 4, 2025
Downgrades: Neutral
Price Target: n/a
Current: $34.29
Upside: -
Lantheus Holdings
Sep 3, 2024
Initiates: Buy
Price Target: $175
Current: $83.33
Upside: +110.01%
Intuitive Surgical
Aug 2, 2024
Upgrades: Buy
Price Target: $380 → $510
Current: $466.30
Upside: +9.37%
GE HealthCare Technologies
Jan 19, 2023
Initiates: Buy
Price Target: n/a
Current: $69.58
Upside: -